Download PLR Content Directory Barbados: Clobex

Clobex is a brand name of clobetasol topical, approved by the FDA in the following formulation(s):

CLOBEX (clobetasol propionate - lotion; topical)

Manufacturer: GALDERMA LABS LP

Approval date: July 24, 2003

Strength(s): 0.05% ^[RLD]^[AB]

CLOBEX (clobetasol propionate - shampoo; topical)

Manufacturer: GALDERMA LABS

Approval date: February 5, 2004

Strength(s): 0.05% ^[RLD]^[AB]

CLOBEX (clobetasol propionate - spray; topical)

Manufacturer: GALDERMA LABS LP

Approval date: October 27, 2005

Strength(s): 0.05% ^[RLD]^[AT]

Has a generic version of Clobex been approved?

A generic version of Clobex has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Clobex and have been approved by the FDA:

clobetasol propionate lotion; topical

Manufacturer: ACTAVIS MID ATLANTIC

Approval date: December 4, 2008

Strength(s): 0.05% ^[AB]

clobetasol propionate shampoo; topical

Manufacturer: ACTAVIS MID ATLANTIC

Approval date: June 7, 2011

Strength(s): 0.05% ^[AB]

clobetasol propionate spray; topical

Manufacturer: PADDOCK LLC

Approval date: June 16, 2011

Strength(s): 0.05% ^[AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Clobex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
Patent 5,972,920
Issued: October 26, 1999
Inventor(s): Seidel; William E.
Assignee(s): Dermalogix Partners, Inc.
One or more formulations for treating psoriasis and other skin disorders characterized by redness, itching, flaking, scaling, and plaque-type growth. The formulation includes a carrier component, one or more active ingredient components, and a surfactant component. The carrier preferably includes an alcohol in substantially equal volume with isopropyl myristate. The active ingredient component preferably includes a superpotent or high-potency corticosteroid such as clobetasol propionate, an anti-flaking ingredient such as zinc pyrithione, or a combination of the two. It may also include an anti-fungal compound. The surfactant component preferably includes an alkyl sulfate such as sodium lauryl sulfate. The formulations made by applied topically either in spray form or as a direct-contact liquid.
Patent expiration dates:
- February 12, 2018
  ✓
  Drug product

Composition and method for treatment of psoriasis
Patent 5,990,100
Issued: November 23, 1999
Inventor(s): Rosenberg; E. William & Glenn; Thomas M. & Skinner, Jr.; Robert B. & Noah; Patricia W.
Assignee(s): Panda Pharmaceuticals, L.L.C.
The University of Tennessee Research Corporation
Pharmaceutical compositions and methods for use in the treatment of psoriasis, having isopropyl myristate as a first active ingredient and a different anti-psoriatic agent as a second active ingredient; preferably they are combined in the same pharmaceutical composition.
Patent expiration dates:
- March 24, 2018
  ✓
  Patent use: TWICE DAILY TOPICAL TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS.
  ✓
  Drug product

Topically applicable O/W emulsions having high glycol content and at least one biologically active agent
Patent 6,106,848
Issued: August 22, 2000
Inventor(s): Preuilh; Isabelle & Willcox; Nathalie
Assignee(s): Centre International de Recherches Dermatologiques
Stable, topically applicable oil-in-water bioaffecting emulsions having intermediate viscosity, characteristically ranging from 3 to 10 Pa.multidot.s, comprise (a) from 30% to 50% by weight of at least one pro-penetrating glycol, (b) at least one emulsifying agent, advantageously an anionic amphiphilic polymer, and (c) at least one biologically active agent, for example an active agent that modulates skin differentiation and/or proliferation and/or pigmentation, an anti-inflammatory, an antibacterial, an antifungal, etc.
Patent expiration dates:
- September 22, 2017

Foaming composition for washing and treating hair and/or scalp based on an active principle
Patent 7,316,810
Issued: January 8, 2008
Inventor(s): Preuilh; Isabelle & Guise; Anne-Emmanuelle & Willcox; Nathalie
Assignee(s): Galderma S.A.
The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterized in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent.
Patent expiration dates:
- June 17, 2019
  ✓
  Drug product

Foaming compositions for hair care
Patent 7,700,081
Issued: April 20, 2010
Inventor(s): Preuilh; Isabelle & Guise; Anne-Emmanuelle & Willcox; Nathalie
Assignee(s): Galderma S.A.
The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterised in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent.
Patent expiration dates:
- January 3, 2022
  ✓
  Patent use: TOPICAL TREATMENT OF SCALP PSORIASIS

Foaming composition for washing and treating hair and/or scalp based on an active principle
Patent 8,066,975
Issued: November 29, 2011
Inventor(s): Preuilh; Isabelle & Guise; Anne-Emmanuelle & Willcox; Nathalie
Assignee(s): Galderma S.A.
The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterized in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent.
Patent expiration dates:
- June 17, 2019
  ✓
  Drug product

Foaming compositions for hair care
Patent 8,066,976
Issued: November 29, 2011
Inventor(s): Preuilh; Isabelle & Guise; Anne-Emmanuelle & Willcox; Nathalie
Assignee(s): Galderma S.A.
The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterised in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent.
Patent expiration dates:
- June 17, 2019
  ✓
  Drug product

Download PLR Content Directory Barbados

Wednesday, 28 July 2010

Clobex